Echinacea and its alkylamides: Effects on the influenza A-induced secretion of cytokines, chemokines, and PGE2 from RAW 264.7 macrophage-like cells

International Immunopharmacology

Volumn 10, Issue 10, 2010, Pages 1268-1278

  Cech, Nadja B ^a   Kandhi, Vamsikrishna ^a   Davis, Jeanine M ^b   Hamilton, Amy ^b   Eads, Dawn ^b   Laster, Scott M ^b  

^a UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Alkylamide; Anti inflammatory; Echinacea; H1N1 influenza; Isobutylamide; Plant extracts

Indexed keywords

ALCOHOL; ALKALOID DERIVATIVE; AMIDE; BIOLOGICAL MARKER; CAFTARIC ACID; CHEMOKINE; CICHORIC ACID; CYTOKINE; DODECA DIENOIC ACID ISOBUTYLAMIDE; DODECA TETRAENOIC ACID ISOBUTYLAMIDE; ECHINACEA PURPUREA EXTRACT; GRANULOCYTE COLONY STIMULATING FACTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E2; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNDECA DIENE 8,10 DIYNIOC ACID ISOBUTYLAMIDE; UNDECA ENE 8,10 DIYNOIC ACID ISOBUTYLAMIDE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL LINE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG DETERMINATION; DRUG EFFICACY; DRUG INHIBITION; ECHINACEA; ECHINACEA PURPUREA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOMODULATION; IMMUNOPRECIPITATION; IN VITRO STUDY; INFLUENZA VIRUS A H1N1; MACROPHAGE; MEDIATOR; NONHUMAN; PLANT GROWTH; PLANT ROOT; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; UNITED STATES; VIRUS STRAIN;

AMIDES; ANIMALS; CAFFEIC ACIDS; CELL LINE; CYTOKINES; DINOPROSTONE; ECHINACEA; GENE EXPRESSION REGULATION; INFLUENZA A VIRUS; MACROPHAGES; MICE; MOLECULAR STRUCTURE; NORTH CAROLINA; PLANT ROOTS;

EID: 77957245871     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2010.07.009     Document Type: Article

References (42)

1. U.S. nutrition industry overview. Nutr Bus J 2009, 14:1-13.
2. Keller K. Legal requirements for the use of phytopharmaceutical drugs in the Federal Republic of Germany. J Ethnopharmacol 1991, 32:225-229.
3. Grimm W., Muller H.-H. A randomized controlled clinical trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of colds and respiratory infections. Am J Med 1999, 106:138-143.
4. Melchart D., Linde K., Worku F., Sarkady L., Holzmann M., Jurcic K., et al. Results of five randomized studies on the immunomodulatory activity of preparations of Echinacea. J Altern Complement Med 1995, 1:145-160.
5. Turner R.B., Bauer R., Woelkart K., Hulsey T.C., Gangemi J.D. An evaluation of Echinacea angustifolia in an experimental rhinovirus infection. N Engl J Med 2005, 353:341-348.
6. Turner R.B., Riker D.K., Gangmi J.D. Ineffectiveness of Echinacea for prevention of experimental rhinovirus colds. Antimicorb Agents Chemother 2000, 44:1708-1709.
7. Matthias A., Addison R.S., Agnew L.L., Bone K.M., Watson K., Lehmann R.P. Comparison of Echinacea alkylamide pharmacokinetics between liquid and tablet preparations. Phytomedicine 2007, 14:587-590.
8. Shah S.A., Sander S., White C.M., Rinaldi M., Coleman C.I. Evaluation of Echinacea for the prevention and treatment of the common cold: a meta-analysis. Lancet Infect Dis 2007, 7:473-480.
9. Bauer R. Echinacea: biological effects and active principles. Phytomedicines of Europe 1998, 140-157. American Chemical Society, Washington, DC. L.D. Lawson, R. Bauer (Eds.).
10. Burger R.A., Torres A.R., Reed W.P., Caldwell V.D., Hughes B.G. Echinacea-induced cytokine production by human macrophages. Int J Immunopharmacol 1997, 19:371-379.
11. Pugh N.D., Balacandran P., Lata H., Dayan F.E., Joshi V., Bedir E., et al. Melanin: dietary mucosal immune modulator from Echinacea and other botanical supplements. Int Immunopharmacol 2005, 5:637-647.
12. Rininger J.A., Kickner S., Chigurupati P., McLean A., Franck Z. Immunopharmacological activity of Echinacea preparations following simulated digestion on murine macrophages and human peripheral blood mononuclear cells. J Leukoc Biol 2000, 68:503-510.
13. Vohra S., Adams D., Hudson J.B., Moore J.A., Vimalanathan S., Sharma M., et al. Selection of natural health products for clinical trials: a preclinical template. Can J Physiol Pharmacol 2009, 87:371-378.
14. Luettig B., Steinmuller C., Gifford G.E., Wagner H., Lohmann-Matthes M.L. Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea. J Natl Cancer Inst 1989, 81:669-675.
15. Roesler J., Emmendorffer A.C., Steinmuller C., Luettig B., Wagner H., Lohman-Matthes M.L. Application of purified polysaccharides from cell cultures of the plant Echinacea purpurea to test subjects mediates activation of the phagocyte system. Int Immunopharmacol 1991, 13:931-941.
16. Steinmuller C., Roesler J., Grottrup E., Franke G., Wagner H., Lohmann-Matthes M.L. Polysaccharides isolated from plant cell cultures of Echinacea purpurea enhance the resistance of immunosuppressed mice against systemic infections with Candida albicans and Listeria monocytogenes. Int J Immunopharmacol 1993, 15:605-614.
17. Wagner H., Stuppner H., Puhlmann J., Schafer W., Zenk M.H. Immunologically active polysaccharides of Echinacea purpurea cell cultures. Phytochemistry 1988, 27:119-126.
18. Pugh N.D., Tamta H., Balachandran P., Wu X., Howell J., Dayan F.E., et al. The majority of in vitro macrophage activation exhibited by extracts of some immune enhancing botanicals is due to bacterial lipoproteins and lipopolysaccharides. Int Immunopharmacol 2008, 8:1023-1032.
19. Tamta H., Pugh N.D., Balachandran P., Moraes R., Sumiyanto J., Pasco D.S. Variability in in vitro macrophage activation by commercially diverse bulk Echinacea plant material is predominantly due to bacterial lipoproteins and lipopolysaccharides. J Agric Food Chem 2008, 56:10552-10556.
20. Chen Y., Fu T., Tao T., Yang J., Chang Y., Wang M., et al. Macrophage activating effects of new alkamides from the roots of Echinacea species. J Nat Prod 2005, 68:649-652.
21. Matthias A., Banbury L., Stevenson L.M., Bone K.M., Leach D.N., Lehmann R.P. Alkylamides from Echinacea modulate induced immune responses in macrophages. Immunol Investig 2007, 36:117-130.
22. Sharma M., Anderson S.A., Schoop R., Hudson J.B. Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract. Antivir Res 2009, 83:165-170.
23. Gertsch J., Schoop R., Kuenzle U., Suter A. Echinacea alkylamides modulate TNF-alpha gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways. FEBS Lett 2004, 577:563-569.
24. Raduner S., Majewska A., Chen J.-Z., Xie X.-Q., Hamon J., Faller B., et al. Alkylamides from Echinacea are a new class of cannabinomimetics. J Biol Chem 2006, 281.
25. Stevenson L.M., Matthias A., Banbury L., Penman K.G., Bone K.M., Leach D.L., et al. Modulation of macrophage immune responses by Echinacea. Molecules 2005, 10:1279-1285.
26. Woelkart K., Xu W., Pei Y., Makriyannis A., Picone R., Bauer R. The endocannabinoid system as a target for alkamides from Echinacea angustifolia roots. Planta Med 2005, 71:701-705.
27. Kurokawa M., Imakita M., Kumeda C.A., Shiraki K. Cascade of fever production in mice infected with influenza virus. J Med Virol 1996, 50:152-158.
28. Langhans W. Anorexia of infection: current prospects. Nutrition 2000, 16:996-1005.
29. Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect Dis 2005, 5:718-725.
30. Baracos V., Rodemann H.P., Dinarello C.A., Goldberg A.L. Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever. N Engl J Med 1983, 308:553-558.
31. Bauer R., Reminger P. TLC and HPLC analysis of alkamides in Echinacea drugs. Planta Med 1989, 55:367-371.
32. Cech N.B., Eleazer M.S., Shoffner L.T., Davis A.C., Crosswhite M.R., Mortenson A.M. High performance liquid chromatography/electrospray ionization mass spectrometry for simultaneous analysis of alkylamides and caffeic acid derivatives from Echinacea purpurea extracts. J Chromatogr A 2006, 1103:219-228.
33. Spelman K., Wetschler M., Cech N.B. Comparison of alkylamide yield in ethanolic extracts prepared from fresh versus dry Echinacea purpurea utilizing HPLC-ESI-MS. J Pharm Biomed Anal 2009, 49:1141-1149.
34. Ehrhardt C., Seyer R., Hrincius E.R., Eierhoff T., Wolff T., Ludwig S. Interplay between influenza A virus and the innate immune signaling. Microbe Infect 2010, 12:81-87.
35. Teferedegne B., Green M., Guo Z., Boss J. Mechanism of action of a distal NF-kappab-dependent enhancer. Mol Cell Biol 2006, 26.
36. Nishizawa M., Nagata S. Regulatory elements responsible for inducible expression of the granulocyte colony-stimulating factor gene in macrophages. Mol Cell Biol 1990, 10:2002-2011.
37. Spelman K., Liams-Hauser K., Cech N., Taylor E., Smirnoff N., Wenner C. Role for PPARγ in IL-2 inhibition in t cells by Echinacea-derived undeca-2e-ene-8,10-diynoic acid isobutylamide. Int Immunopharmacol 2009, 9:1260-1264.
38. Sharma M., Arnason J.T., Hudson J.B. Echinacea extracts modulate the production of multiple transcription factors in uninfected cells and rhinovirus-infected cells. Phytother Res 2006, 20:1074-1079.
39. Eads D., Hansen R., Oyegunwa A., Cecil C., Culver C., Scholle F., et al. Terameprocol, a methylated derivative of nordihydroguaiaretic acid, inhibits production of prostaglandins and several key inflammatory cytokines and chemokines. J Inflamm 2009, 6:2.
40. Lalone C.A., Rizshsky L., Hammer K.D.P., Lankun W., Solco A.K.S., Yum M., et al. Endogenous levels of Echinacea alkylamides and ketones are important contributors to the inhibition of prostaglandin E2 and nitric oxide production in cultured macrophages. J Agric Food Chem 2009, 57:8820-8830.
41. Clancy R., Varenika B., Huang W., Ballou L., Attur M., Amin A.R., et al. Nitric oxide synthase/COX cross talk: nitric oxide activates COX-1 but inhibits COX-2-derived prostaglandin production. J Immunol 2000, 165:1582-1587.
42. Morrison D.C., Jacobs D.M. Inhibition of lipopolysaccharide-initiated activation of serum complement by polymyxin B1. Infect Immun 1976, 13:298-301.